Osseotite Implant Reference List | 13 |
PMID Publication Authors Journal Citation Title
24890861 Schropp L, Wenzel A, Spin- Neto R, Stavropoulos A.
25830402 Vigolo P, Mutinelli S, Zaccaria M, Stellini E.
24107257 Zuffetti F, Testori T, Capelli M, Rossi MC, Del Fabbro M.
2016 to date
27560668 Cooper LF, Tarnow D, Froum S, Moriarty J, De Kok IJ.
25180683 Glibert M, Vervaeke S, De Bruyn H, Ostman PO.
Clin Oral Implants Res 2015; 26:492-500.
Int J Oral Maxillofac Implants 2015; 30:411- 418.
Clin Implant Dent Relat Res 2015 Jan; 17 Suppl 1: e168-176.
Int J Periodontics Restorative Dent 2016; 36:631-642.
Clin Implant Dent Relat Res 2016; 18( 1): 129- 137.
27004291 |
Kitajima H, Ogawa T. |
Int J Oral Maxillofac |
|
|
Implants 2016; 31:439- |
|
|
447. |
26988739 Mazzocco F, Jimenez D, Barallat L, Paniz G, Del Fabbro M, Nart J.
Clin Oral Implants Res 2016 Mar 14. Epub ahead of print.
Fate of the buccal bone at implants placed early, delayed, or late after tooth extraction analyzed by cone beam CT: 10-year results from a randomized, controlled, clinical study. †
Clinical evaluation of marginal bone level change around multiple adjacent implants restored with splinted and nonsplinted restorations: a 10-year randomized controlled trial.
The topical administration of bisphosphonates in implant surgery: a randomized split-mouth prospective study with a follow-up up to 5 years. †
Comparison of marginal bone changes with internal conus and external hexagon design implant systems: a prospective, randomized study.
Clinical and radiographic comparison between platformshifted and nonplatform-shifted implant: a one-year prospective study. †
The use of photofunctionalized implants for low or extremely low primary stability cases.
Bone volume changes after immediate implant placement with or without flap elevation.
Study Design
Patients( N)
Study Implant( N)
Prospective |
63 |
Osseotite |
|
|
63 |
Prospective, Randomizedcontrolled
Prospective, Randomizedcontrolled, Split-mouth
Prospective, Randomizedcontrolled
Prospective, Randomizedcontrolled
44 Osseotite 132
39 Osseotite Tapered 55
18 Osseotite 42
48 Osseotite 2 115
Retrospective |
38 |
Osseotite |
|
|
55 |
Prospective |
35 |
Osseotite |
|
|
Tapered |
|
|
35 |
% CSR Duration
% CSRs By Variables
10 years 90.9 Early 95.4 Delayed 100 Late
10 years 99.2
5 years 100 Bisphosphonates 91.3 Control
3 years 100
1 year 100
3 years 98.2
6 months 100 IRES
Key: PMID: PubMed identification number, N = total number; % CSR = cumulative survival rate percentage; w / PSw = with platform switching( Prevail Implants); IL = Immediate loading; IOL = Immediate occlusal loading; IRES = Immediate replacement of extraction socket; AUG = Augmented( grafted).